| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,926 | 3,781 | 3,795 | 3,324 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 2,926 | 3,781 | 3,795 | 3,324 | | | Operating Expenses | | Research Development | 4,774 | 7,096 | 7,289 | 8,236 | | Selling General and Administrative | 1,719 | 1,453 | 1,930 | 1,538 | | Non Recurring |
-
|
-
|
-
| (3) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,567) | (4,768) | (5,424) | (6,447) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2 | 11 | (244) | 11 | | Earnings Before Interest And Taxes | (3,565) | (4,757) | (5,668) | (6,436) | | Interest Expense | (3) | 52 | 13 | (22) | | Income Before Tax | (3,562) | (4,809) | (5,681) | (6,414) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,562) | (4,809) | (5,681) | (6,414) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,562) | (4,809) | (5,681) | (6,414) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,562) | ($4,809) | ($5,681) | ($6,414) |
|
0.10% Nasdaq 
Income Statement
